SB-8

Bevacizumab · Samsung Bioepis Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SB-8, covering 2024-12-16 to 2024-12-16. Get the full timeline:

Most recent: Clinical Trial Update: A Study Comparing SB8 and Avastin® in Patients With Advanced Non-squamous Non-small Cell Lung Cancer [Phase 3]